Training & Capacity Building

Here we are committed to establishing a future generation of rare disease researchers by enhancing early career opportunities and delivering cross disciplinary training.

Research lead

Assoc. Prof Martin Higgs

Martin Higgs is an Associate Professor for Genomics and Rare Disease in the Department of Cancer and Genomic Sciences. He leads a research group focused on the cellular response to genotoxic stress and is the Deputy Director of the Centre for Rare Disease Studies (CRDS) Birmingham. As the lead for Training & Capacity Building within the Accelerating Rare Disease Trials (ARDT) programme, he is committed to developing a sustainable training pathway for early career researchers in rare diseases. His research expertise lies in understanding the role of lysine methylation in DNA damage response, neurodevelopment, and rare disease mechanisms. He has a particular interest in neurodevelopmental disorders caused by mutations in the lysine methylation apparatus, as well as the impact of chronic viral infections on DNA repair and tumourigenesis

University lead

Professor John Sayer - Newcastle University

Professor John Sayer is a Clinical Professor of Renal Medicine at Newcastle University and an Honorary Consultant Nephrologist at Newcastle upon Tyne Hospitals NHS Foundation Trust. He is also Deputy Dean of Clinical Medicine.

Professor Amy Jayne McKnight - Queens University Belfast

Professor AJ McKnight is a Professor of Molecular Epidemiology and Public Health at Queen’s University Belfast, co-leading the Epidemiology and Public Health Research Group. She directs the Northern Ireland Rare Disease Research Centre and plays a key role in developing data-driven approaches to improve rare disease identification and treatment.

Area Overview

Building skills and expertise to advance rare disease research.

There is currently no structured training pathway for early career researchers, including allied healthcare professionals, in rare disease research. This gap is particularly evident in clinical trials methodology, trial delivery, and stakeholder engagement. The absence of rare disease-specific doctoral training programmes, limited post-doctoral funding, and a lack of cross-disciplinary training opportunities have contributed to career instability and challenges in retaining skilled researchers. Addressing these barriers is essential for building a sustainable rare disease research workforce and driving long-term improvements in patient care. 

Our approach will focus on establishing a comprehensive training and capacity-building framework to support early career researchers in rare diseases. This includes the development of a translational science/clinical PhD training scheme to build expertise in rare disease research, alongside a dedicated professional and post-doctoral training fellowship scheme to provide structured career progression. Additionally, we will launch a cross-disciplinary training platform that integrates key areas such as genomics and rare disease clinical trials, ensuring researchers develop the complementary skill sets needed for translational research. 

By embedding training and capacity building at the heart of the ARDT project, we will create a robust pipeline of skilled researchers. This effort will enhance career stability, foster interdisciplinary collaboration, and improve retention within the field. Ultimately, our work will strengthen the UK’s capability to conduct high-quality rare disease research, supporting the development and delivery of innovative treatments for people living with rare conditions. 

 

Interested in working with the team?

We are always looking for talented researchers, clinicians, and industry partners to join our efforts in accelerating rare disease trials. Whether you’re interested in research collaboration, clinical trial design, or patient engagement, we’d love to hear from you.